Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07c9542186133097bd6bbb7d92393090 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2400-173 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-225 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-201 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-202 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23C9-1234 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-6427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-6472 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-6436 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K50-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23K20-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23C9-1315 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-202 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-201 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23C9-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23C9-123 |
filingDate |
1998-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2000-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ba60e0e7f49a3eda79d2347f0d8cbb5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_516046c99d3e5b203a306a8415a95e83 |
publicationDate |
2000-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6020376-A |
titleOfInvention |
Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations |
abstract |
Methods of treating animals to maintain or elevate CD-4 and CD-8 cell levels and to prevent or alleviate the adverse effects on the animal caused by the production or exogenous administration of tumor necrosis factor (TNF) or by a virus consist of administering to the animal a safe and effective amount of a conjugated linoleic acid (CLA) or a substance which is converted in the animal into CLA. A method of preparing CLA employing a bacteria isolated from a rat colon also is disclosed. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004067573-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011184063-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010297196-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009023807-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003215465-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010113810-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6479683-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010113595-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7105336-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7935729-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009036410-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8114903-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7964641-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003091654-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008090908-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6395782-B1 |
priorityDate |
1995-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |